Erytech Pharma SA - Stock Price History | ERYP

Historical daily share price chart and data for Erytech Pharma SA since 2021 adjusted for splits. The latest closing stock price for Erytech Pharma SA as of September 27, 2021 is 6.01.
  • The all-time high Erytech Pharma SA stock closing price was 30.30 on December 05, 2017.
  • The Erytech Pharma SA 52-week high stock price is 13.00, which is 116.3% above the current share price.
  • The Erytech Pharma SA 52-week low stock price is 4.10, which is 31.8% below the current share price.
  • The average Erytech Pharma SA stock price for the last 52 weeks is 7.18.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Erytech Pharma SA Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 7.2964 7.2004 10.9700 3.8500 9.2300 25.15%
2019 6.4485 7.0100 9.6400 4.0200 7.3750 8.88%
2018 14.5491 21.6451 23.2798 5.5400 6.7737 -69.24%
2017 23.6097 24.7500 30.3000 17.9300 22.0200 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.167B $0.004B
Erytech Pharma S.A. operates as a biopharmaceutical company. It discovers and developes therapies for rare forms of cancer and orphan diseases. The company's product pipeline consists of eryaspase, erymethionase, eryminase, ERYZYME and ERYMMUNE which are in clinical stages. It operates primarily in France and the United States. Erytech Pharma S.A. is based in France.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29